Financhill
Back

SpringWorks Therapeutics Vs. Genpact Industry Stock Comparison

Sell
20

SWTX
SpringWorks Therapeutics

Last Price:
35.63
Seasonality Move:
16.3%
Buy
52

G
Genpact

Last Price:
38.77
Seasonality Move:
-1.54%
Sell
20
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $37.42. The Score for SWTX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $39.29. The Score for G is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $39.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 44.81 Sell
Chaikin Money Flow: 815408 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.96 - 41) Sell
Bollinger Bands (100): (36.43 - 42.95) Sell

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 64.31 Buy
Chaikin Money Flow: 957990 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.91 - 39.27) Buy
Bollinger Bands (100): (31.36 - 36.92) Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.75 Sell
20-day SMA: 39.55 Sell
50-day SMA: 38.15 Sell
200-day SMA: 41.2 Sell
8-day EMA: 38.42 Sell
20-day EMA: 38.82 Sell
50-day EMA: 38.73 Sell
200-day EMA: 38.57 Sell

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.7 Buy
20-day SMA: 38.86 Buy
50-day SMA: 35.84 Buy
200-day SMA: 34.16 Buy
8-day EMA: 38.81 Buy
20-day EMA: 38.31 Buy
50-day EMA: 36.56 Buy
200-day EMA: 35.06 Buy

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.60 per share, an increase this year of $1.13 per share, and an increase next year of $1.54 per share.

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.07 per share, an increase this year of $0.27 per share, and an increase next year of $0.23 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):